Outcome, complications and future fertility in women treated with uterine artery embolization and methotrexate for non-tubal ectopic pregnancy

被引:27
作者
Krissi, Haim [1 ,2 ]
Hiersch, Liran [2 ]
Stolovitch, Natan [1 ,2 ]
Nitke, Shmuel [1 ,2 ]
Wiznitzer, Arnon [1 ,2 ]
Peled, Yoav [1 ,2 ]
机构
[1] Helen Schneider Hosp Women, Rabin Med Ctr, Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
Interstitial pregnancy; Cervical pregnancy; Cesarean scar pregnancy; Methotrexate; Uterine artery embolization; CERVICAL PREGNANCY; DOSE METHOTREXATE; MANAGEMENT;
D O I
10.1016/j.ejogrb.2014.09.026
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
Objective: To determine the effectiveness and safety of uterine artery methotrexate (MTX) infusion and embolization combined with systemic MTX for treatment of non-tubal ectopic pregnancy. Study design: We retrospectively reviewed the electronic files of all women admitted to a single tertiary, university-affiliated medical center with a diagnosis of non-tubal (cervical, interstitial or cesarean section scar) ectopic pregnancy, who were treated by a combination of uterine artery MIX infusion and embolization and systemic MIX between January 2001 and March 2014. The treatment protocol included a total of 4 MIX injections in doses of 1 mg/kg/day every other day (days 1, 3, 5, 7 of the protocol) alternating with folinic acid 0.1 mg/kg (days 2, 4, 6, 8). The first or second MIX dose was administered by transcatheter intra-arterial injection during the embolization procedure just before injecting Gelfoam for bilateral uterine artery occlusion, and the remaining doses were given intramuscularly. Results: During the study period, 25 women underwent uterine artery infusion and embolization combined with systemic MTX treatment for non-tubal ectopic pregnancy. Ten of the pregnancies were cervical, 9 were interstitial, and 6 were cesarean scar pregnancies. Mean gestational age and beta-human chorionic gonadotropin (beta-HCG) level at admission were 68.6 +/- 12.9 days and 14,179 (range 43661596) IU/L, respectively. Treatment was successful in 24 patients (96%) with mean beta-HCG resolution time of 52.6 (6-147) days. Mild immediate side effects were reported including 8 cases (32%) of abdominal discomfort, 3 cases (12%) of groin or leg pain and 3 cases (12%) of puncture-site local skin infection. No serious immediate side effects such as internal vascular bleeding, sepsis or early liver or renal failure were observed. Among 12 women who stated that they tried to conceive and were more than a year from the treatment, 10 (83.3%) had subsequent pregnancy. Conclusion: A combination of uterine artery MIX infusion and embolization with systemic MTX seems to be an effective and safe treatment for non-tubal ectopic pregnancies in women who try to conceive. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:172 / 176
页数:5
相关论文
共 23 条
[1]
The Analysis of Efficacy and Failure Factors of Uterine Artery Methotrexate Infusion and Embolization in Treatment of Cesarean Scar Pregnancy [J].
An, Xiao ;
Ming, Xu ;
Li, Ke ;
Wang, Jingbing .
SCIENTIFIC WORLD JOURNAL, 2013,
[2]
BABSON AL, 1991, J CLIN IMMUNOASSAY, V14, P83
[3]
Barnhart K, 2001, Expert Opin Pharmacother, V2, P409, DOI 10.1517/14656566.2.3.409
[4]
Sites of ectopic pregnancy: a 10 year population-based study of 1800 cases [J].
Bouyer, J ;
Coste, J ;
Fernandez, H ;
Pouly, JL ;
Job-Spira, N .
HUMAN REPRODUCTION, 2002, 17 (12) :3224-3230
[5]
Factors influencing the success of conservative treatment of interstitial pregnancy [J].
Cassik, P ;
Ofili-Yebovi, D ;
Yazbek, J ;
Lee, C ;
Elson, J ;
Jurkovic, D .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2005, 26 (03) :279-282
[6]
Treating non-tubal ectopic pregnancy [J].
Chetty, Maya ;
Elson, Janine .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2009, 23 (04) :529-538
[7]
Comparison of single and multiple dose methotrexate therapy for unruptured tubal ectopic pregnancy: a prospective randomized study [J].
Guven, Emine Seda Guvendag ;
Dilbaz, Serdar ;
Dilbaz, Berna ;
Yildirim, Burcu Aykan ;
Akdag, Derya ;
Haberal, Ali .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2010, 89 (07) :889-895
[8]
Prognostic factors for an unsatisfactory primary methotrexate treatment of cervical pregnancy: a quantitative review [J].
Hung, TH ;
Shau, WY ;
Hsieh, TT ;
Hsu, JJ ;
Soong, YK ;
Jeng, CJ .
HUMAN REPRODUCTION, 1998, 13 (09) :2636-2642
[9]
First-trimester diagnosis and management of pregnancies implanted into the lower uterine segment Cesarean section scar [J].
Jurkovic, D ;
Hillaby, K ;
Woelfer, B ;
Lawrence, A ;
Salim, R ;
Elson, CJ .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2003, 21 (03) :220-227
[10]
Efficacy of methotrexate treatment in viable and nonviable cervical pregnancies [J].
Kung, FT ;
Chang, SY .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 181 (06) :1438-1444